|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Cutsem E and Oliveira J: ESMO
Guidelines Working Group: Advanced colorectal cancer: ESMO clinical
recommendations for diagnosis, treatment and follow-up. Ann Oncol.
20:61–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoo PS, Lopez-Soler RI, Longo WE and Cha
CH: Liver resection for metastatic colorectal cancer in the age of
neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer.
6:202–207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oh-I S, Shimizu H, Satoh T, Okada S,
Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, et
al: Identification of nesfatin-1 as a satiety molecule in the
hypothalamus. Nature. 443:709–712. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garcia-Galiano D, Navarro VM, Gaytan F and
Tena-Sempere M: Expanding roles of NUCB2/nesfatin-1 in
neuroendocrine regulation. J Mol Endocrinol. 45:281–290. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Qi C, Li L, Luo F and Xu Y:
Clinical significance of NUCB2 mRNA expression in prostate cancer.
J Exp Clin Cancer Res. 32:562013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang H, Qi C, Wang A, Yao B, Li L, Wang Y
and Xu Y: Prognostication of prostate cancer based on NUCB2 protein
assessment: NUCB2 in prostate cancer. J Exp Clin Cancer Res.
32:772013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kan JY, Yen MC, Wang JY, Wu DC, Chiu YJ,
Ho YW and Kuo PL: Nesfatin-1/Nucleobindin-2 enhances cell
migration, invasion, and epithelial-mesenchymal transition via
LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer. Oncotarget.
7:31336–31349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi C, Ma H, Zhang HT, Gao JD and Xu Y:
Nucleobindin 2 expression is an independent prognostic factor for
clear cell renal cell carcinoma. Histopathology. 66:650–657. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki S, Takagi K, Miki Y, Onodera Y,
Akahira J, Ebata A, Ishida T, Watanabe M, Sasano H and Suzuki T:
Nucleobindin 2 in human breast carcinoma as a potent prognostic
factor. Cancer Sci. 103:136–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ramanjaneya M, Tan BK, Rucinski M, Kawan
M, Hu J, Kaur J, Patel VH, Malendowicz LK, Komarowska H, Lehnert H,
et al: Nesfatin-1 inhibits proliferation and enhances apoptosis of
human adrenocortical H295R cells. J Endocrinol. 226:1–11. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu Y, Pang X, Dong M, Wen F and Zhang Y:
Nesfatin-1 inhibits ovarian epithelial carcinoma cell proliferation
in vitro. Biochem Biophys Res Commun. 440:467–472. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Edge SB and Compton CC: The American Joint
Committie on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Field K and Lipton L: Metastatic
colorectal cancer-past, progress and future. World J Gastroenterol.
13:3806–3815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kraljevic Pavelic S, Sedic M, Bosnjak H,
Spaventi S and Pavelic K: Metastasis: New perspectives on an old
problem. Mol Cancer. 10:222011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao X, Liu XM and Zhou LH: Recent progress
in research on the distribution and function of NUCB2/nesfatin-1 in
peripheral tissues. Endocr J. 60:1021–1027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takagi K, Miki Y, Tanaka S, Hashimoto C,
Watanabe M, Sasano H, Ito K and Suzuki T: Nucleobindin 2 (NUCB2) in
human endometrial carcinoma: A potent prognostic factor associated
with cell proliferation and migration. Endocr J. 63:287–299. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Qi C, Wang A, Li L and Xu Y: High
expression of nucleobindin 2 mRNA: An independent prognostic factor
for overall survival of patients with prostate cancer. Tumour Biol.
35:2025–2028. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang M, Zhang Z, Wang C, Li K, Li S, Boden
G, Li L and Yang G: Nesfatin-1 action in the brain increases
insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced
insulin resistance. Diabetes. 61:1959–1968. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Wang
Z, Xie H, Dai B, Xu J and Ye D: High NUCB2 expression level
represents an independent negative prognostic factor in Chinese
cohorts of non-metastatic clear cell renal cell carcinoma patients.
Oncotarget. 8:35244–35254. 2017.PubMed/NCBI
|
|
23
|
Kaplan MA, Isikdogan A, Gumus M, Arslan
UY, Geredeli C, Ozdemir N, Koca D, Dane F, Suner A, Elkiran ET, et
al: Childhood, adolescents, and young adults (≤25 y) colorectal
cancer: Study of Anatolian Society of Medical Oncology. J Pediatr
Hematol Oncol. 35:83–89. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao L, Bao F, Yan J, Liu H, Li T, Chen H
and Li G: Poor prognosis of young patients with colorectal cancer:
A retrospective study. Int J Colorectal Dis. 32:1147–1156. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taggarshe D, Rehil N, Sharma S, Flynn JC
and Damadi A: Colorectal cancer: Are the ‘young’ being overlooked?
Am J Surg. 205:312–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeo SA, Chew MH, Koh PK and Tang CL: Young
colorectal carcinoma patients do not have a poorer prognosis: A
comparative review of 2,426 cases. Tech Coloproctol. 17:653–661.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
You YN, Xing Y, Feig BW, Chang GJ and
Cormier JN: Young-onset colorectal cancer: Is it time to pay
attention? Arch Intern Med. 172:287–289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ashktorab H, Paydar M, Namin HH, Sanderson
A, Begum R, Brim H, Panchal H, Lee E, Kibreab A, Nouraie M and
Laiyemo AO: Prevalence of colorectal neoplasia among young African
Americans and hispanic Americans. Dig Dis Sci. 59:446–450. 2014.
View Article : Google Scholar : PubMed/NCBI
|
